ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
3 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
2 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
3 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
1 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
2 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
2
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Approvals & expected drilling timetable for Li Project
|
|
itsagas
|
133 |
55K |
5 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
133
|
55K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
0 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
0
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Approvals & expected drilling timetable for Li Project
|
|
itsagas
|
133 |
55K |
1 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
133
|
55K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
10 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
10
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
16 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
16
|
|
Charts
|
RDN |
Re:
RDN Charts
|
|
itsagas
|
574 |
275K |
2 |
20/08/24 |
20/08/24 |
Charts
|
574
|
275K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
15 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
15
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
4 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
366
|
120K
|
4
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
14 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
366
|
120K
|
14
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
366
|
120K
|
1
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
6 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
366
|
120K
|
6
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
2 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
366
|
120K
|
2
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
3 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
366
|
120K
|
3
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
5 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
366
|
120K
|
5
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
itsagas
|
366 |
120K |
4 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
366
|
120K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
4 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
6 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
6 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
7 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
238
|
67K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
5 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
8 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
8
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
itsagas
|
8.3K |
3.5M |
2 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
8.3K
|
3.5M
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
5 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.2K
|
316K
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
itsagas
|
8.3K |
3.5M |
27 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
8.3K
|
3.5M
|
27
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
1 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
238
|
67K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
5 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
238
|
67K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
238
|
67K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
238
|
67K
|
3
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
itsagas
|
1.2K |
316K |
7 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
1.2K
|
316K
|
7
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
4 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
58
|
16K
|
4
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
10 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
58
|
16K
|
10
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
itsagas
|
58 |
16K |
2 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
238
|
67K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
238
|
67K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
itsagas
|
238 |
67K |
5 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
238
|
67K
|
5
|
|